Skip to content

10-QAccepted Aug 12, 4:20 PM ET

ArriVent BioPharma, Inc. 10-Q

AVBPArriVent BioPharma, Inc.

Accepted (ET)

4:20 PM

Aug 12, 2026

Filed

Aug 12, 2026

Documents

63

Size

6.1 MB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.